Rockwell (RMTI), NxStage (NXST) Enter Manufacturing Agreement
- Procter & Gamble (PG) Misses Q2 EPS by 12c; Sees FY15 Core Earnings In-Line to Down Versus Prior Year
- Caterpillar (CAT) Misses Q4 EPS by 20c; Guides FY15 EPS Well Below the Street
- Pre-Open Stock Movers 01/27: (SIMG) (CRRC) (COMM) Higher; (MSFT) (CAT) (PG) (UTX) Lower (more...)
- Pfizer (PFE) Tops Q4 EPS by 1c; Issues Light FY15 Outlook
- Dec. Durable Goods Orders -3.4% vs 0.3% Expected
Rockwell Medical Technologies (NASDAQ: RMTI) has signed a contract with NxStage Medical, Inc. (Nasdaq: NXST) to manufacture dialysate concentrate for the NxStage System One", the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration. The contract term is for two years.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rockwell Medical (RMTI) FDA Triferic Approval 'De-Risk' the Story, Summer Street Says
- Obama Administration to Adjust How Doctors, Hospitals Receive Medicare Reimbursement (CYH) (THC) (HCA)
- Pre-Open Stock Movers 01/26: (OCN) (OLED) (RGP) (MWV) Higher; (MAT) (STX) (PRE) (Lower (more...)
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!